Unknown

Dataset Information

0

Molecular analysis of small tissue samples obtained via transbronchial lung biopsy using radial probe endobronchial ultrasound.


ABSTRACT: BACKGROUND:Radial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose peripheral lung cancer. The aim was to identify the accuracy of molecular analysis that were performed with EBUS-GS specimens in patients with non-small cell lung cancer (NSCLC). METHOD:From December 2015 to September 2017, we retrospectively studied 91 patients with peripheral NSCLC who underwent surgery after EBUS-GS. Epidermal growth factor receptor (EGFR) mutational and anaplastic lymphoma kinase (ALK) translocation status obtained from surgical specimens served as the references. RESULTS:Compared to the reference data, EGFR mutational testing of EBUS-GS specimens was in 97% agreement, and the ? coefficient was 0.931 (P< 0.001). In addition, on ALK translocation testing, the results of all 91 patients were in agreement with the reference data (concordance rate of 100%, ? coefficient 1.000; P< 0.001). CONCLUSION:We found that EBUS-GS could be used for molecular diagnosis, such as EGFR mutational and ALK translocation status, in patients with peripheral NSCLC.

SUBMITTER: Kim I 

PROVIDER: S-EPMC6391011 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular analysis of small tissue samples obtained via transbronchial lung biopsy using radial probe endobronchial ultrasound.

Kim Insu I   Eom Jung Seop JS   Kim Ah Rong AR   Lee Chang Hun CH   Lee Geewon G   Jo Eun Jung EJ   Kim Mi-Hyun MH   Mok Jeong Ha JH   Lee Kwangha K   Kim Ki Uk KU   Park Hye-Kyung HK   Lee Min Ki MK  

PloS one 20190226 2


<h4>Background</h4>Radial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose peripheral lung cancer. The aim was to identify the accuracy of molecular analysis that were performed with EBUS-GS specimens in patients with non-small cell lung cancer (NSCLC).<h4>Method</h4>From December 2015 to September 2017, we retrospectively studied 91 patients with peripheral NSCLC who underwent surgery after EBUS-GS. Epidermal growth factor receptor (EGFR) mutational and anaplast  ...[more]

Similar Datasets

| S-EPMC7263016 | biostudies-literature
| S-EPMC7388566 | biostudies-literature
| S-EPMC7440722 | biostudies-literature
| S-EPMC8555788 | biostudies-literature
| S-EPMC5777651 | biostudies-literature
| S-EPMC7165338 | biostudies-literature
| S-EPMC7843011 | biostudies-literature
| S-EPMC5863144 | biostudies-literature
| S-EPMC6090614 | biostudies-literature
| S-EPMC3981557 | biostudies-literature